{"filing":{"accession_number":"0001161697-26-000188","cik":"0000704440","ticker":"KRMD","company_name":"KORU Medical Systems, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"form_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000188/form_8-k.htm"},"events":[{"id":24425,"run_id":22131,"accession_number":"0001161697-26-000188","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"KORU Medical issued a press release on August 5, 2026 announcing financial results for Q2 2026 (ended June 30, 2026) and updating full-year 2026 guidance. The disclosure reports net revenues of $12.0 million (18% growth), gross profit of $7.8 million (20% growth), and net income of $0.25 million, along with revised revenue guidance of $47.5–$48.5 million and positive adjusted EBITDA for the full year. This is a standard quarterly earnings release with material financial metrics and forward guidance, furnished as Exhibit 99.1.","company_name":"KORU Medical Systems, Inc.","ticker":"KRMD","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":24970,"accession_number":"0001161697-26-000188","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"KORU Medical issued a press release on August 5, 2026 announcing financial results for Q2 2026 (ended June 30, 2026) and updating full-year 2026 guidance. The disclosure reports net revenues of $12.0 million (18% growth), gross profit of $7.8 million (20% growth), and net income of $0.25 million, along with revised revenue guidance of $47.5–$48.5 million and positive adjusted EBITDA for the full year. This is a standard quarterly earnings release with material financial metrics and forward guidance, furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:34:34.874678+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24970,"accession_number":"0001161697-26-000188","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"KORU Medical issued a press release on August 5, 2026 announcing financial results for Q2 2026 (ended June 30, 2026) and updating full-year 2026 guidance. The disclosure reports net revenues of $12.0 million (18% growth), gross profit of $7.8 million (20% growth), and net income of $0.25 million, along with revised revenue guidance of $47.5–$48.5 million and positive adjusted EBITDA for the full year. This is a standard quarterly earnings release with material financial metrics and forward guidance, furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:34:34.874678+00:00","company_name":"KORU Medical Systems, Inc.","ticker":"KRMD","filing_date":"2026-08-05"}]}